BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12829822)

  • 1. Drug resistance patterns of recombinant herpes simplex virus DNA polymerase mutants generated with a set of overlapping cosmids and plasmids.
    Bestman-Smith J; Boivin G
    J Virol; 2003 Jul; 77(14):7820-9. PubMed ID: 12829822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
    Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
    Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
    Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
    Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral susceptibility of recombinant Herpes simplex virus 1 strains with specific polymerase amino acid changes.
    Rose R; Brunnemann AK; Baukmann S; Bühler S; Fickenscher H; Sauerbrei A; Zell R; Krumbholz A
    Antiviral Res; 2021 Nov; 195():105166. PubMed ID: 34419483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidine kinase mutations conferring acyclovir resistance in herpes simplex type 1 recombinant viruses.
    Sergerie Y; Boivin G
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3889-92. PubMed ID: 16982796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential impact of various substitutions at codon 715 in region II of HSV-1 and HCMV DNA polymerases.
    Zarrouk K; Zhu X; Goyette N; Piret J; Shi R; Boivin G
    Antiviral Res; 2021 Apr; 188():105046. PubMed ID: 33588012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
    Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
    J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus.
    Sauerbrei A; Deinhardt S; Zell R; Wutzler P
    Antiviral Res; 2010 Jun; 86(3):246-52. PubMed ID: 20211650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
    Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
    Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the contribution of the herpes simplex virus DNA polymerase to spontaneous mutations.
    Duffy KE; Quail MR; Nguyen TT; Wittrock RJ; Bartus JO; Halsey WM; Leary JJ; Bacon TH; Sarisky RT
    BMC Infect Dis; 2002 May; 2():7. PubMed ID: 12019036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of mutations in DNA polymerase and thymidine kinase genes of herpes simplex virus clinical isolates resistant to antiherpetic drugs].
    Korovina AN; Gus'kova AA; Skoblov MIu; Andronova VL; Galegov GA; Kochetkov SN; Kukhanova MK; Skoblov IuS
    Mol Biol (Mosk); 2010; 44(3):488-96. PubMed ID: 20608173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of DNA polymerase-associated acyclovir-resistant herpes simplex virus type 1: mutations, sensitivity to antiviral compounds, neurovirulence, and in-vivo sensitivity to treatment.
    Wang LX; Takayama-Ito M; Kinoshita-Yamaguchi H; Kakiuchi S; Suzutani T; Nakamichi K; Lim CK; Kurane I; Saijo M
    Jpn J Infect Dis; 2013; 66(5):404-10. PubMed ID: 24047739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A point mutation within conserved region VI of herpes simplex virus type 1 DNA polymerase confers altered drug sensitivity and enhances replication fidelity.
    Hwang YT; Zuccola HJ; Lu Q; Hwang CB
    J Virol; 2004 Jan; 78(2):650-7. PubMed ID: 14694096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence Analysis of Herpes Simplex Virus 1 Thymidine Kinase and DNA Polymerase Genes from over 300 Clinical Isolates from 1973 to 2014 Finds Novel Mutations That May Be Relevant for Development of Antiviral Resistance.
    Schmidt S; Bohn-Wippert K; Schlattmann P; Zell R; Sauerbrei A
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4938-45. PubMed ID: 26055375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and genotypic characterization of induced acyclovir-resistant clinical isolates of herpes simplex virus type 1.
    Hussin A; Md Nor NS; Ibrahim N
    Antiviral Res; 2013 Nov; 100(2):306-13. PubMed ID: 24055837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children.
    Wang Y; Wang Q; Zhu Q; Zhou R; Liu J; Peng T
    J Clin Virol; 2011 Oct; 52(2):107-12. PubMed ID: 21778105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.
    Saijo M; Suzutani T; De Clercq E; Niikura M; Maeda A; Morikawa S; Kurane I
    Antiviral Res; 2002 Dec; 56(3):253-62. PubMed ID: 12406508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain.
    Saijo M; Suzutani T; Morikawa S; Kurane I
    Antimicrob Agents Chemother; 2005 Feb; 49(2):606-11. PubMed ID: 15673740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.